[go: up one dir, main page]

BR0212931A - Composição farmacêutica de liberação prolongada contendo metformina - Google Patents

Composição farmacêutica de liberação prolongada contendo metformina

Info

Publication number
BR0212931A
BR0212931A BR0212931-0A BR0212931A BR0212931A BR 0212931 A BR0212931 A BR 0212931A BR 0212931 A BR0212931 A BR 0212931A BR 0212931 A BR0212931 A BR 0212931A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
metformin
prolonged release
release pharmaceutical
containing prolonged
Prior art date
Application number
BR0212931-0A
Other languages
English (en)
Inventor
Deepak Murpani
Ashish Madan
Vinod Kumar Arora
Rajiv Malik
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of BR0212931A publication Critical patent/BR0212931A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA DE LIBERAçãO PROLONGADA CONTENDO METFORMINA". A presente invenção refere-se a uma composição farmacêutica de liberação prolongada, que contém metformina e um polímero controlador de taxa, e a um processo para a preparação destes.
BR0212931-0A 2001-09-28 2002-09-27 Composição farmacêutica de liberação prolongada contendo metformina BR0212931A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1002DE2001 IN192180B (pt) 2001-09-28 2001-09-28
PCT/IB2002/003997 WO2003028704A1 (en) 2001-09-28 2002-09-27 Extended release pharmaceutical composition containing metformin

Publications (1)

Publication Number Publication Date
BR0212931A true BR0212931A (pt) 2004-10-13

Family

ID=11097117

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212931-0A BR0212931A (pt) 2001-09-28 2002-09-27 Composição farmacêutica de liberação prolongada contendo metformina

Country Status (12)

Country Link
US (1) US20040059001A1 (pt)
EP (1) EP1434568A1 (pt)
JP (1) JP2005507896A (pt)
KR (1) KR20040063900A (pt)
CN (1) CN1582145A (pt)
AR (1) AR037326A1 (pt)
BR (1) BR0212931A (pt)
EA (1) EA200400487A1 (pt)
IN (1) IN192180B (pt)
MX (1) MXPA04002910A (pt)
WO (1) WO2003028704A1 (pt)
ZA (1) ZA200402532B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1515701B1 (en) * 2002-06-17 2014-09-17 Inventia Healthcare Private Limited Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide
EP1646374A1 (en) * 2003-06-16 2006-04-19 Ranbaxy Laboratories, Ltd. Extended-release tablets of metformin
WO2005092293A1 (en) * 2004-03-22 2005-10-06 Ranbaxy Laboratories Limited Formulations of metformin
US20060088594A1 (en) * 2004-10-08 2006-04-27 Pilgaonkar Pratibha S Highly compressible controlled delivery compositions of metformin
SI1811957T1 (sl) * 2004-10-19 2009-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Trden farmacevtski sestavek, ki obsega donepezil hidroklorid
WO2006082523A2 (en) * 2005-01-25 2006-08-10 Aurobindo Pharma Limited Pharmaceutical sustained release composition of metformin
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US20100152299A1 (en) * 2005-05-10 2010-06-17 Madhav Vasanthavada Process for making compositions with poorly compressible therapeutic compounds
KR100780553B1 (ko) * 2005-08-18 2007-11-29 한올제약주식회사 메트포르민 서방정 및 그의 제조방법
WO2007056205A2 (en) * 2005-11-04 2007-05-18 Eastman Chemical Company Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents
BRPI0605967A (pt) * 2006-12-20 2008-08-12 Medley S A Ind Farmaceutica composição farmacêutica de liberação controlada, forma farmacêutica de liberação controlada e processo para obtenção de forma farmacêutica
US8058312B2 (en) 2007-01-29 2011-11-15 Hanall Biopharma Co., Ltd. N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
KR101597004B1 (ko) 2013-07-25 2016-02-23 씨제이헬스케어 주식회사 서방형 메트포르민과 속방형 HMG-CoA 환원효소 억제제를 포함하는 복합제제
CN106138020A (zh) * 2015-04-03 2016-11-23 中国人民解放军第三军医大学第三附属医院 双胍类药物在制备预防或减弱肺纤维化的药物中的应用
CN107049980A (zh) * 2017-04-01 2017-08-18 重庆康刻尔制药有限公司 一种盐酸二甲双胍缓释片及其制备方法
KR20210081290A (ko) * 2019-12-23 2021-07-01 주식회사 대웅제약 메트포르민 서방성 제제 및 이의 제조 방법
CN111588701B (zh) * 2020-05-25 2021-04-23 上海普康药业有限公司 一种盐酸二甲双胍缓释片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813064D0 (en) * 1988-06-02 1988-07-06 Euro Celtique Sa Controlled release dosage forms having defined water content
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
DE4432757A1 (de) * 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
ES2216335T3 (es) * 1997-12-08 2004-10-16 Bristol-Myers Squibb Company Nuevas sales de metformina y procedimiento.
EP2332522A3 (en) * 1998-03-19 2011-12-07 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets

Also Published As

Publication number Publication date
IN192180B (pt) 2004-03-06
JP2005507896A (ja) 2005-03-24
MXPA04002910A (es) 2004-07-05
CN1582145A (zh) 2005-02-16
ZA200402532B (en) 2005-01-04
KR20040063900A (ko) 2004-07-14
AR037326A1 (es) 2004-11-03
US20040059001A1 (en) 2004-03-25
EA200400487A1 (ru) 2004-10-28
EP1434568A1 (en) 2004-07-07
WO2003028704A1 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
BR0212931A (pt) Composição farmacêutica de liberação prolongada contendo metformina
BR0114410A (pt) Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade
BR9916835A (pt) Composição de galantamina de liberação controlada
NO20041270D0 (no) Farmasoytiske sammensetninger som innbefatter kolloidal silikondioksid
BR0315984A (pt) Composições fotocrÈmicas e artigos que transmitem luz
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
HK1084941A1 (en) Compounds and their use
BR0210028A (pt) Agentes antibacterianos
BR0316421A (pt) Composição farmacêutica compreendendo micropartìculas de octreotìdeo
BRPI0620229A8 (pt) formulação
BR0300709A (pt) Sal de perindopril e as composições farmacêuticas contendo o mesmo
BR0214559A (pt) sais de ácido succìnico do 5,8,14-triazatetraciclo [10.3.1.0<2,11>.0<4,9>]-hexadeca-2(11),3,5,7,9-penteno e suas composições farmacêuticas
BR0116332A (pt) Processo para o aumento da estabilidade
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
BR0215027A (pt) Derivados de 6-aminomorfinano, processo de preparação para o mesmo e sua aplicação
NO20064808L (no) Orale matrixformuleringer med licarbazepin
BRPI0415123A (pt) uso de l-butilftalida e respectiva composição farmacêutica
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
BR0208813A (pt) Composições contendo imidazotriazinona para a aplicação nasal
EA200600590A1 (ru) Фармацевтические композиции модафинила с модифицированным высвобождением
BR0315836A (pt) Derivados de [6,7-dihidro-5h-imidazol[1,2-alfa]imadazol-3-sulfonila mino]-propionamida, composição farmacêutica, uso do mesmo, bem como processo para sua preparação
BR9915692A (pt) Monohidrato de bromidrato de eletriptano
BRPI0404824A (pt) Processos para preparar uma composição de polìmero, um polìmero multifuncional, e uma composição multifuncional para modificação de cabelos
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]